Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4D | Q08499 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | HPGD | P15428 | 1/20 | 1.00 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.76 |
| ▸ | GABRA1 | P14867 | 5/20 | 0.73 |
| ▸ | GABRA5 | P31644 | 5/20 | 0.73 |
| ▸ | GABRA3 | P34903 | 5/20 | 0.73 |
| ▸ | GABRA2 | P47869 | 5/20 | 0.73 |
| ▸ | GABRG2 | P18507 | 4/20 | 0.73 |
| ▸ | GABRB3 | P28472 | 4/20 | 0.73 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.73 |
| ▸ | GABRP | O00591 | 2/20 | 0.73 |
| ▸ | GABRD | O14764 | 2/20 | 0.73 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.73 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.73 |
| ▸ | GABRE | P78334 | 2/20 | 0.73 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.73 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.73 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.73 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nitrazepam SCHEMBL29408437 | 1.00 | PDE4D (1.00) | PDE4DLMNAHPGDCHRM1GABRA1 | |
| Nitrazepam SCHEMBL9747297 | 1.00 | PDE4D (1.00) | PDE4DLMNAHPGDCHRM1GABRA1 | |
| Nitrazepam SCHEMBL28564999 | 0.93 | PDE4D (0.87) | PDE4DLMNAHPGDCHRM1GABRA1 | |
| SCHEMBL7721819 | 0.88 | LMNA (0.78) | PDE4DLMNAHPGDCHRM1GABRA1 | |
| SCHEMBL2615370 | 0.88 | PDE4D (0.78) | PDE4DLMNAHPGDCHRM1GABRA1 | |
| SCHEMBL13284399 | 0.88 | LMNA (0.78) | PDE4DLMNAHPGDCHRM1GABRA1 | |
| Nimetazepam SCHEMBL1003526 | 0.88 | LMNA (0.81) | PDE4DLMNAHPGDCHRM1GABRA1 | |
| SCHEMBL7322518 | 0.86 | CHRM1 (1.00) | PDE4DLMNAHPGDCHRM1GABRA1 | |
| Clonazepam SCHEMBL20771795 | 0.85 | GABRA1 (0.96) | PDE4DLMNAHPGDCHRM1GABRA1 | |
| Nitrazepam SCHEMBL31373270 | 0.84 | LMNA (0.73) | PDE4DLMNAHPGDCHRM1GABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 17684 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3607938-B1 | PHARMACEUTICAL COMPOSITION | SOVIC BRKICIC LJILJANA (HR) | 2026-05-27 | — | — | EP | claimed |
| US-20260137654-A1 | COMPOUNDS AND METHODS FOR TREATING AN EPILEPTIC DISORDER | THE REGENTS OF THE UNIV OF CALIFORNIA (US) | 2026-05-21 | — | — | US | claimed |
| US-12624036-B2 | Method of treating post-traumatic stress disorder | INTRA-CELLULAR THERAPIES, INC. (US) | 2026-05-12 | — | — | US | claimed |
| US-12624037-B2 | Method of treating agitation, aggressive behavior, and impulse control disorder | INTRA-CELLULAR THERAPIES, INC. (US) | 2026-05-12 | — | — | US | claimed |
| US-20260117775-A1 | Water Pump | COAVIS (KR) | 2026-04-30 | — | — | US | claimed |
| US-20260083706-A1 | 5HT AGONISTS FOR TREATING DISORDERS | UNIV CALIFORNIA (US) | 2026-03-26 | — | — | US | claimed |
| US-20260076953-A1 | METHODS OF DIAGNOSING AND TREATING ADHD IN BIOMARKER POSITIVE SUBJECTS | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2026-03-19 | — | — | US | claimed |
| EP-4696377-A2 | 5HT AGONISTS FOR TREATING DISORDERS | The Regents of the University of California (US) | 2026-02-18 | — | — | EP | claimed |
| EP-3507371-B1 | COMPOSITIONS FOR TREATING DISEASES AND DISORDERS OF THE NERVOUS SYSTEM | UNIV RUTGERS (US) | 2026-01-28 | — | — | EP | claimed |
| EP-4684775-A1 | ORAL SOLUTION COMPRISING NITRAZEPAM | LABOMED PHARMACEUTICAL COMPANY S.A. (GR) | 2026-01-28 | — | — | EP | claimed |
| EP-0216555-A2 | Use of dioxopiperidine derivatives in the treatment of anxiety, for the reduction of chronic abnormally high brain levels of serotonin or 5-hydroxy-indoleacetic acid, and in the treatment of bacterial or viral infections | BTG INTERNATIONAL LIMITED (GB) | 1987-04-01 | — | — | EP | claimed |
| US-4557934-A | ALONG WITH A DIOL PYRROLIDONE OR AN AZACYCLOPENTAN-2-ONE | THE PROCTER & GAMBLE COMPANY (US) | 1985-12-10 | — | — | US | claimed |
| EP-0150721-A2 | Drug | Firma Paliz, Ziegler (CH) | 1985-08-07 | — | — | EP | claimed |
| EP-0110955-A1 | BRAIN-SPECIFIC DRUG DELIVERY. | UNIV FLORIDA (US) | 1984-06-20 | — | — | EP | claimed |
| US-4431742-A | RADIOIMMUNOASSAY; INCUBATION OF LABELED DRUG USING PELLETS OF HOMOGENIZED BRAIN AS CARRIERS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1984-02-14 | — | — | US | claimed |
| WO-1983003968-A1 | BRAIN-SPECIFIC DRUG DELIVERY | UNIVERSITY OF FLORIDA (US) | 1983-11-24 | — | — | WO | claimed |
| US-4369172-A | Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose | FOREST LABORATORIES INC. (US) | 1983-01-18 | — | — | US | claimed |
| US-4316897-A | TRANQUILIZERS | HOFFMANN-LA ROCHE INC. (US) | 1982-02-23 | — | — | US | claimed |
| EP-0025546-A2 | Therapeutical use of tranquillizing benzodiazepine derivatives and mixtures containing them | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1981-03-25 | — | — | EP | claimed |
| US-4028467-A | Analgesic compositions comprising levo-propoxyphene and benzo diazepine and process | BERGER FRANK M | 1977-06-07 | — | — | US | claimed |